Dermatologic Disease clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Sorry, not currently recruiting here
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Los Angeles, California and other locations
Last updated: